Cytokine biomarkers to predict antitumor responses to nivolumab suggested in a phase 2 study for advanced melanoma
暂无分享,去创建一个
Y. Fujisawa | H. Iizuka | F. Otsuka | H. Ihn | H. Uchi | N. Yamazaki | H. Tahara | H. Uhara | Y. Kiyohara | H. Minami | K. Iwatsuki | T. Isei | T. Takenouchi | J. Uehara